scholarly article | Q13442814 |
P356 | DOI | 10.1002/GLIA.20501 |
P8608 | Fatcat ID | release_aozlgbvy2jccnjb467rewaadsa |
P698 | PubMed publication ID | 17348023 |
P2093 | author name string | Abhijit Guha | |
David H Gutmann | |||
Rubing Xing | |||
Larry S Sherman | |||
Weiping Su | |||
P2860 | cites work | The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins | Q24324729 |
HGF/SF-met signaling in the control of branching morphogenesis and invasion | Q28202466 | ||
Neurofibromatosis type 1 - a model for nervous system tumour formation? | Q28265284 | ||
Fully human monoclonal antibodies to hepatocyte growth factor with therapeutic potential against hepatocyte growth factor/c-Met-dependent human tumors | Q28295039 | ||
Neurofibromatosis 1 (NF1) heterozygosity results in a cell-autonomous growth advantage for astrocytes | Q28506980 | ||
Localization and functional role of hepatocyte growth factor (HGF) and its receptor c-met in the rat developing cerebral cortex | Q28569831 | ||
Neurotrophic effect of hepatocyte growth factor on central nervous system neurons in vitro | Q28573753 | ||
Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1 | Q28593162 | ||
The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21 | Q28609120 | ||
Expression of c-Met in developing rat hippocampus: evidence for HGF as a neurotrophic factor for calbindin D-expressing neurons | Q30940447 | ||
Cerebrovascular abnormalities in a population of children with neurofibromatosis type 1. | Q30982269 | ||
Post-ischemic delayed expression of hepatocyte growth factor and c-Met in mouse brain following focal cerebral ischemia | Q31040245 | ||
Signaling pathways in the induction of c-met receptor expression by its ligand scatter factor/hepatocyte growth factor in human glioblastoma. | Q32134611 | ||
Intracranial gliomas in neurofibromatosis type 1. | Q33723870 | ||
Epilepsy in neurofibromatosis 1. | Q34208209 | ||
Astrocyte-specific inactivation of the neurofibromatosis 1 gene (NF1) is insufficient for astrocytoma formation. | Q34441257 | ||
Astrocytic purinergic signaling coordinates synaptic networks | Q34457580 | ||
Cardiovascular disease in neurofibromatosis 1: report of the NF1 Cardiovascular Task Force | Q34785638 | ||
Intracranial neoplasms in children with neurofibromatosis 1. | Q34982069 | ||
Malignant peripheral nerve sheath tumour arising within neurofibroma. An immunohistochemical analysis in the comparison between benign and malignant components | Q35399426 | ||
Role of glial cells in cerebral ischemia | Q36104660 | ||
Optic-nerve gliomas, chiasmal gliomas and neurofibromatosis type 1. | Q36377540 | ||
Expression and functional interaction of hepatocyte growth factor-scatter factor and its receptor c-met in mammalian brain | Q36382913 | ||
Crosstalk between hepatocyte growth factor and integrin signaling pathways | Q36404210 | ||
Expression of HGF and cMet in the developing and adult brain | Q36888704 | ||
Inactivation of NF1 in CNS causes increased glial progenitor proliferation and optic glioma formation | Q37383632 | ||
Deficits in memory and hippocampal long-term potentiation in mice with reduced calbindin D28K expression. | Q37458180 | ||
Hepatocyte growth factor and c-MET in benign and malignant peripheral nerve sheath tumors | Q38473715 | ||
Hepatocyte growth factor/scatter factor is a motogen for interneurons migrating from the ventral to dorsal telencephalon | Q38498293 | ||
Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice | Q40377847 | ||
Role of hepatocyte growth factor activator (HGF activator) in invasive growth of human glioblastoma cells in vivo. | Q40384156 | ||
Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras | Q40424687 | ||
CD44-independent hepatocyte growth factor/c-Met autocrine loop promotes malignant peripheral nerve sheath tumor cell invasion in vitro. | Q40598012 | ||
An astrocytic basis of epilepsy | Q42218578 | ||
Neuronal or glial progeny: regional differences in radial glia fate | Q42438070 | ||
PKC, p42/44 MAPK and p38 MAPK regulate hepatocyte growth factor secretion from human astrocytoma cells. | Q42525071 | ||
Concomitant expression of hepatocyte growth factor (HGF), HGF activator and c-met genes in human glioma cells in vitro | Q42803690 | ||
The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae | Q43515231 | ||
Gliomas presenting after age 10 in individuals with neurofibromatosis type 1 (NF1). | Q43707439 | ||
Genetic disruption of cortical interneuron development causes region- and GABA cell type-specific deficits, epilepsy, and behavioral dysfunction. | Q44281916 | ||
Pten loss causes hypertrophy and increased proliferation of astrocytes in vivo | Q45134010 | ||
Susceptibility of primary culture neurons from rats of different ages to encephalomyocarditis (EMC) virus infection | Q45711008 | ||
Gene transfer of hepatocyte growth factor gene improves learning and memory in the chronic stage of cerebral infarction | Q45856361 | ||
Astrocyte-neurone communication following oxygen-glucose deprivation | Q46725790 | ||
Pten regulates neuronal soma size: a mouse model of Lhermitte-Duclos disease | Q47198015 | ||
Immunohistochemistry with antibodies to hepatocyte growth factor and its receptor protein (c-MET) in human brain tissues | Q48172929 | ||
Seizures in neurofibromatosis 1. | Q48311205 | ||
Cytokines regulate c-Met expression in cultured astrocytes | Q48402762 | ||
Identification of HGF-like protein as a novel neurotrophic factor for avian dorsal root ganglion sensory neurons. | Q52135618 | ||
Simultaneous up-regulation of urokinase-type plasminogen activator (uPA) and uPA receptor by hepatocyte growth factor/scatter factor in human glioma cells. | Q55474924 | ||
Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study. | Q55481914 | ||
COGNITIVE FUNCTION AND ACADEMIC PERFORMANCE IN CHILDREN WITH NEUROFIBROMATOSIS TYPE 1 | Q57394335 | ||
Disruption of the hyaluronan-based extracellular matrix in spinal cord promotes astrocyte proliferation | Q57839705 | ||
Hepatocyte growth factor specifically expressed in microglia activated Ras in the neurons, similar to the action of neurotrophic factors | Q71692067 | ||
Reversion of human glioblastoma malignancy by U1 small nuclear RNA/ribozyme targeting of scatter factor/hepatocyte growth factor and c-met expression | Q73004517 | ||
Cooperation between HGF and CNTF in promoting the survival and growth of sensory and parasympathetic neurons | Q73419103 | ||
Hepatocyte growth factor stimulates the proliferation and migration of oligodendrocyte precursor cells | Q74721095 | ||
P433 | issue | 7 | |
P304 | page(s) | 723-733 | |
P577 | publication date | 2007-05-01 | |
P1433 | published in | Glia | Q15716658 |
P1476 | title | Mice with GFAP-targeted loss of neurofibromin demonstrate increased axonal MET expression with aging | |
P478 | volume | 55 |
Search more.